RSNA: fMRI Neuroimaging Measures Retinoblastoma Chemotherapy’s Impacts on Children’s Visual Cortex
Retinoblastoma chemotherapy is associated with decreased visual cortex activation among children.
Diagnosis & Disease Information
Chemotherapy/RT Regimens Preserve Larynx Better than RT Alone
Locoregional control and larynx preservation significantly improved with use of concomitant cisplatin/radiation therapy (RT) vs induction cisplatin/fluorouracil followed by RT or RT alone.
Safety-Net Hospital Care Good for Head, Neck Cancer
Surgical care provided to head and neck cancer patients without increase in mortality, morbidity, costs
Induction Chemo + Surgery No Better than Surgery Alone for Advanced Oral SCC
Induction chemotherapy with docetaxel, cisplatin, and fluorouracil followed by surgery failed to improve survival vs up-front surgery in patients with locally advanced resectable oral squamous cell carcinoma, a study in the Journal of Clinical Oncology online November 5 has found.
ASTRO: Doxepin Rinse Reduces Oral Mucositis Pain Among Radiotherapy Patients
Doxepin mouth rinse alleviates radiation therapy-associated mouth sore and oral mucositis (OM) pain among patients with head and neck cancer.
Acupuncture Ameliorates Chronic Xerostomia After Radiation for Head and Neck Cancer
Compared with group oral care education, eight sessions of weekly group acupuncture provided significantly better relief of symptoms in patients with chronic radiation-induced xerostomia.
Gene Signature Validated for Oral Cancer Metastases
Clinical assessment with the expression signature decreases rate of undetected nodal metastases in early-stage squamous cell carcinoma of the oral cavity.
New Genetic Test Diagnoses Premalignant HNSCC
The Malignancy Index Diagnostic System (qMIDS) test quantitatively diagnosed and objectively stratified cancer aggressiveness in patients with head and neck squamous cell carcinomas.
ESMO: Tumor HPV Status Does Not Affect Survival Benefits of Adding Cetuximab to Platinum-Based Chemotherapy For Head and Neck Cancer
The survival benefits of adding cetuximab to chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck are not affected by tumors’ human papillomavirus (HPV) status.
IMRT Yields ‘Excellent’ Long-term Outcomes in Nasopharyngeal Carcinoma
Nearly 4 years after definitive intensity-modulated radiation therapy for nasopharyngeal carcinoma, patients experienced “excellent” outcomes and manageable oral toxicities.
- Loading...
Loading...
Loading... 
Loading...